Delivery Order SPE2DB20D2014-SPE2DB25FA45E

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA45E
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,580.93 Firm Fixed Price Delivery Order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a period of performance through November 29, 2024.

The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award reviewed has no set-aside designation, indicating open competition for the procurement. AmerisourceBergen is the prime contractor, and no subcontractors are mentioned. The Defense Logistics Agency, a component of the Department of Defense, is the funding agency for this award, which supports military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/26/25, 10:00 AM